Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rapid Micro Biosystems (RPID) Net Margin (2020 - 2025)

Historic Net Margin for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to 146.78%.

  • Rapid Micro Biosystems' Net Margin rose 21200.0% to 146.78% in Q3 2025 from the same period last year, while for Sep 2025 it was 145.11%, marking a year-over-year increase of 398200.0%. This contributed to the annual value of 167.16% for FY2024, which is 658300.0% up from last year.
  • As of Q3 2025, Rapid Micro Biosystems' Net Margin stood at 146.78%, which was up 21200.0% from 163.29% recorded in Q2 2025.
  • Rapid Micro Biosystems' Net Margin's 5-year high stood at 117.62% during Q4 2024, with a 5-year trough of 486.47% in Q1 2021.
  • In the last 5 years, Rapid Micro Biosystems' Net Margin had a median value of 237.43% in 2024 and averaged 257.3%.
  • Within the past 5 years, the most significant YoY rise in Rapid Micro Biosystems' Net Margin was 2085000bps (2021), while the steepest drop was -1615800bps (2021).
  • Over the past 5 years, Rapid Micro Biosystems' Net Margin (Quarter) stood at 280.43% in 2021, then tumbled by -34bps to 376.02% in 2022, then surged by 53bps to 176.3% in 2023, then soared by 33bps to 117.62% in 2024, then dropped by -25bps to 146.78% in 2025.
  • Its Net Margin stands at 146.78% for Q3 2025, versus 163.29% for Q2 2025 and 156.32% for Q1 2025.